TP53 and non-small cell lung carcinoma: A recent report suggests that inactivation of both FHIT and p53 may have possible synergistic effect resulting in deregulation of proliferation related genes in lung cancer cell lines and tumors [30], particularly in squamous cell carcinoma subtype of non-small cell lung cancer [31].